Global Recombinant Plasma Protein Therapeutics Market Growth (Status and Outlook) 2019-2024

March 2019 | 118 pages | ID: GEF34381C5BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases. Additionally, steady increase in the number of patients with rare hematological diseases and product approvals by regulatory authorities such as the Food and Drug Administration (FDA), European Commission, and Ministry of Health, Labour and Welfare (Japan) are anticipated to drive the market significantly during the forecast period. However, the high cost of treatment and availability of alternative therapies are likely to restrain the global market.

According to this study, over the next five years the Recombinant Plasma Protein Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Recombinant Plasma Protein Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Recombinant Plasma Protein Therapeutics market by product type, application, key companies and key regions.

This study considers the Recombinant Plasma Protein Therapeutics value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

• Chinese Hamster Ovary (CHO) Cell Line
• Baby Hamster Kidney (BHK) Cell Line
• Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

• Hemophilia A
• Hemophilia B
• Von Willebrand Disease
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• CSL Limited
• Shire (Takeda Pharmaceutical Company Limited)
• Octapharma
• Novo Nordisk
• Bayer
• Bioverativ Therapeutics, Inc. (Sanofi)
• Aptevo Therapeutics
• Pharming Group
• Pfizer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Recombinant Plasma Protein Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
• To understand the structure of Recombinant Plasma Protein Therapeutics market by identifying its various subsegments.
• Focuses on the key global Recombinant Plasma Protein Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Recombinant Plasma Protein Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Recombinant Plasma Protein Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2019-2024 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Recombinant Plasma Protein Therapeutics Market Size 2014-2024
  2.1.2 Recombinant Plasma Protein Therapeutics Market Size CAGR by Region
2.2 Recombinant Plasma Protein Therapeutics Segment by Type
  2.2.1 Chinese Hamster Ovary (CHO) Cell Line
  2.2.2 Baby Hamster Kidney (BHK) Cell Line
  2.2.3 Human Embryonic Kidney (HEK) Cell Line
  2.2.4 Others
2.3 Recombinant Plasma Protein Therapeutics Market Size by Type
  2.3.1 Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
  2.3.2 Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate by Type (2014-2019)
2.4 Recombinant Plasma Protein Therapeutics Segment by Application
  2.4.1 Hemophilia A
  2.4.2 Hemophilia B
  2.4.3 Von Willebrand Disease
  2.4.4 Others
2.5 Recombinant Plasma Protein Therapeutics Market Size by Application
  2.5.1 Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
  2.5.2 Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate by Application (2014-2019)

3 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS BY PLAYERS

3.1 Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Players
  3.1.1 Global Recombinant Plasma Protein Therapeutics Market Size by Players (2017-2019)
  3.1.2 Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Players (2017-2019)
3.2 Global Recombinant Plasma Protein Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECOMBINANT PLASMA PROTEIN THERAPEUTICS BY REGIONS

4.1 Recombinant Plasma Protein Therapeutics Market Size by Regions
4.2 Americas Recombinant Plasma Protein Therapeutics Market Size Growth
4.3 APAC Recombinant Plasma Protein Therapeutics Market Size Growth
4.4 Europe Recombinant Plasma Protein Therapeutics Market Size Growth
4.5 Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Growth

5 AMERICAS

5.1 Americas Recombinant Plasma Protein Therapeutics Market Size by Countries
5.2 Americas Recombinant Plasma Protein Therapeutics Market Size by Type
5.3 Americas Recombinant Plasma Protein Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Recombinant Plasma Protein Therapeutics Market Size by Countries
6.2 APAC Recombinant Plasma Protein Therapeutics Market Size by Type
6.3 APAC Recombinant Plasma Protein Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Recombinant Plasma Protein Therapeutics by Countries
7.2 Europe Recombinant Plasma Protein Therapeutics Market Size by Type
7.3 Europe Recombinant Plasma Protein Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Recombinant Plasma Protein Therapeutics by Countries
8.2 Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size by Type
8.3 Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL RECOMBINANT PLASMA PROTEIN THERAPEUTICS MARKET FORECAST

10.1 Global Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2024)
10.2 Global Recombinant Plasma Protein Therapeutics Forecast by Regions
  10.2.1 Global Recombinant Plasma Protein Therapeutics Forecast by Regions (2019-2024)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Recombinant Plasma Protein Therapeutics Forecast by Type
10.8 Global Recombinant Plasma Protein Therapeutics Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 CSL Limited
  11.1.1 Company Details
  11.1.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.1.3 CSL Limited Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.1.4 Main Business Overview
  11.1.5 CSL Limited News
11.2 Shire (Takeda Pharmaceutical Company Limited)
  11.2.1 Company Details
  11.2.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.2.4 Main Business Overview
  11.2.5 Shire (Takeda Pharmaceutical Company Limited) News
11.3 Octapharma
  11.3.1 Company Details
  11.3.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.3.3 Octapharma Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.3.4 Main Business Overview
  11.3.5 Octapharma News
11.4 Novo Nordisk
  11.4.1 Company Details
  11.4.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.4.3 Novo Nordisk Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.4.4 Main Business Overview
  11.4.5 Novo Nordisk News
11.5 Bayer
  11.5.1 Company Details
  11.5.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.5.3 Bayer Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.5.4 Main Business Overview
  11.5.5 Bayer News
11.6 Bioverativ Therapeutics, Inc. (Sanofi)
  11.6.1 Company Details
  11.6.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.6.4 Main Business Overview
  11.6.5 Bioverativ Therapeutics, Inc. (Sanofi) News
11.7 Aptevo Therapeutics
  11.7.1 Company Details
  11.7.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.7.3 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.7.4 Main Business Overview
  11.7.5 Aptevo Therapeutics News
11.8 Pharming Group
  11.8.1 Company Details
  11.8.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.8.3 Pharming Group Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.8.4 Main Business Overview
  11.8.5 Pharming Group News
11.9 Pfizer
  11.9.1 Company Details
  11.9.2 Recombinant Plasma Protein Therapeutics Product Offered
  11.9.3 Pfizer Recombinant Plasma Protein Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  11.9.4 Main Business Overview
  11.9.5 Pfizer News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Recombinant Plasma Protein Therapeutics
Figure Recombinant Plasma Protein Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate 2014-2024 ($ Millions)
Table Recombinant Plasma Protein Therapeutics Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Chinese Hamster Ovary (CHO) Cell Line
Table Major Players of Baby Hamster Kidney (BHK) Cell Line
Table Major Players of Human Embryonic Kidney (HEK) Cell Line
Table Major Players of Others
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Figure Global Chinese Hamster Ovary (CHO) Cell Line Market Size Growth Rate
Figure Global Baby Hamster Kidney (BHK) Cell Line Market Size Growth Rate
Figure Global Human Embryonic Kidney (HEK) Cell Line Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Recombinant Plasma Protein Therapeutics Consumed in Hemophilia A
Figure Global Recombinant Plasma Protein Therapeutics Market: Hemophilia A (2014-2019) ($ Millions)
Figure Global Hemophilia A YoY Growth ($ Millions)
Figure Recombinant Plasma Protein Therapeutics Consumed in Hemophilia B
Figure Global Recombinant Plasma Protein Therapeutics Market: Hemophilia B (2014-2019) ($ Millions)
Figure Global Hemophilia B YoY Growth ($ Millions)
Figure Recombinant Plasma Protein Therapeutics Consumed in Von Willebrand Disease
Figure Global Recombinant Plasma Protein Therapeutics Market: Von Willebrand Disease (2014-2019) ($ Millions)
Figure Global Von Willebrand Disease YoY Growth ($ Millions)
Figure Recombinant Plasma Protein Therapeutics Consumed in Others
Figure Global Recombinant Plasma Protein Therapeutics Market: Others (2014-2019) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Market Size in Hemophilia A Growth Rate
Figure Global Recombinant Plasma Protein Therapeutics Market Size in Hemophilia B Growth Rate
Figure Global Recombinant Plasma Protein Therapeutics Market Size in Von Willebrand Disease Growth Rate
Figure Global Recombinant Plasma Protein Therapeutics Market Size in Others Growth Rate
Table Global Recombinant Plasma Protein Therapeutics Revenue by Players (2017-2019) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Players (2017-2019)
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Players in 2018
Table Global Recombinant Plasma Protein Therapeutics Key Players Head office and Products Offered
Table Recombinant Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions 2014-2019 ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Regions 2014-2019
Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Regions 2014-2019
Figure Americas Recombinant Plasma Protein Therapeutics Market Size 2014-2019 ($ Millions)
Figure APAC Recombinant Plasma Protein Therapeutics Market Size 2014-2019 ($ Millions)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size 2014-2019 ($ Millions)
Table Americas Recombinant Plasma Protein Therapeutics Market Size by Countries (2014-2019) ($ Millions)
Table Americas Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries (2014-2019)
Figure Americas Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries in 2018
Table Americas Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table Americas Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Figure Americas Recombinant Plasma Protein Therapeutics Market Size Market Share by Type in 2018
Table Americas Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) ($ Millions)
Table Americas Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Americas Recombinant Plasma Protein Therapeutics Market Size Market Share by Application in 2018
Figure United States Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Canada Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Table APAC Recombinant Plasma Protein Therapeutics Market Size by Countries (2014-2019) ($ Millions)
Table APAC Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries (2014-2019)
Figure APAC Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries in 2018
Table APAC Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table APAC Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Figure APAC Recombinant Plasma Protein Therapeutics Market Size Market Share by Type in 2018
Table APAC Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) ($ Millions)
Table APAC Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure APAC Recombinant Plasma Protein Therapeutics Market Size Market Share by Application in 2018
Figure China Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Japan Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Korea Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure India Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Australia Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Table Europe Recombinant Plasma Protein Therapeutics Market Size by Countries (2014-2019) ($ Millions)
Table Europe Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries (2014-2019)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries in 2018
Table Europe Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table Europe Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size Market Share by Type in 2018
Table Europe Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) ($ Millions)
Table Europe Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size Market Share by Application in 2018
Figure Germany Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure France Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure UK Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Italy Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Russia Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Spain Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Market Share by Countries in 2018
Table Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Market Share by Type in 2018
Table Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size Market Share by Application in 2018
Figure Egypt Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Israel Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Recombinant Plasma Protein Therapeutics Market Size Growth 2014-2019 ($ Millions)
Figure Global Recombinant Plasma Protein Therapeutics arket Size Forecast (2019-2024) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Market Share Forecast by Regions
Figure Americas Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure APAC Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure United States Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Canada Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Mexico Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Brazil Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure China Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Japan Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Korea Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure India Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Australia Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Germany Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure France Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure UK Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Italy Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Russia Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Spain Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Egypt Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure South Africa Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Israel Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure Turkey Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Figure GCC Countries Recombinant Plasma Protein Therapeutics Market Size 2019-2024 ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Market Share Forecast by Type (2019-2024)
Table Global Recombinant Plasma Protein Therapeutics Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Recombinant Plasma Protein Therapeutics Market Size Market Share Forecast by Application (2019-2024)
Table CSL Limited Basic Information, Head Office, Major Market Areas and Its Competitors
Table CSL Limited Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure CSL Limited Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Shire (Takeda Pharmaceutical Company Limited) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Octapharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Octapharma Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Octapharma Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Novo Nordisk Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novo Nordisk Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Novo Nordisk Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Bayer Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Bioverativ Therapeutics, Inc. (Sanofi) Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Aptevo Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Pharming Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pharming Group Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Pharming Group Recombinant Plasma Protein Therapeutics Market Share (2017-2019)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Recombinant Plasma Protein Therapeutics Revenue and Gross Margin (2017-2019)
Figure Pfizer Recombinant Plasma Protein Therapeutics Market Share (2017-2019)